Video-on-Demand Library

05 November 2020

John Scott, Andreas Brandt, Evgeny Degtyarev and Vladimir Dragalin.

The following aspects are covered:
- Experience with proposals submitted to FDA and EMA on implementation of Estimands
- How the estimands framework facilitates interaction with clinicians in different therapeutic areas
- Common problems where the Estimands framework can help advance research
- Where further discussions and research is required, and particularly where industry and regulators can collaborate
- Issues related to alignment between different estimators to a given estimand
- Special considerations of estimand framework in COVID-19 vaccine trials.

Part of Collection(s)


Upcoming Events

Latest Jobs